HeartBeam, Inc. (BEAT)

NasdaqCM • Currently down 0.03 (-11.00%) in today's trading session

1 member of Congress has disclosed 1 trade in HeartBeam, Inc. (BEAT) via STOCK Act filings. The most recent disclosure was a sale by Brad Schneider on 13 September 2013. Aggregate disclosed activity totals roughly $8K in sales (midpoint estimates from bracketed disclosure amounts).

HeartBeam, Inc. is currently trading at $0.28, positioned at 0% of its 52-week range ($0.27 – $4.00).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$0.28
24h Change
-0.03 (-11.00%)
52 Week Range
$0.27–$4.00
View on NASDAQ

HeartBeam, Inc. Price History and Technical Analysis

Congressional Trading Activity for BEAT

Select to highlight on chart
1 transactions
Compliance: 100%
Brad Schneider13 Sept 201311 Oct 2013SaleStock$1,001-$15,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$17.42M

Volume

658.3K

Beta

-0.85

P/E Ratio

-0.54

Fundamentals

EPS

$-0.51

Div. Yield

-

Open

$0.30

Day Range

$0.27 – $0.30

Company Information

Sector
Healthcare
Industry
Medical - Specialties
Exchange
NASDAQ · USD
Country
US
CEO
Branislav Vajdic
IPO Date
2021-11-16

HeartBeam, Inc. is a development stage company, which engages in cardiovascular diagnostic technology. Its electrocardiogram (ECG) collection device provides physicians with cardiac diagnostic information for a patient that is outside of a medical in...

Earnings

Next Report

Q4 2026

11 Mar

EPS Est.

$-0.06

Rev. Est.

$200K

Days Until

109

Recent Quarters

Q3 202612 Nov
EPS$-0.05
Beat 44.4%
Q2 202613 Aug
EPS$-0.10
Miss 16.3%
Q1 202613 May
EPS$-0.12
Beat 14.3%
Q4 202512 Mar
EPS$-0.14
Miss 7.7%
Q3 202513 Nov
EPS$-0.15
Beat 6.3%
Q2 202513 Aug
EPS$-0.15
Beat 6.3%
Q1 202513 May
EPS$-0.18
Miss 20.0%
Q4 202413 Mar
EPS$-0.18
Beat 5.3%
Q3 20247 Nov
EPS$-0.19
Miss 11.8%
Q2 202414 Aug
EPS$-0.19
Miss 18.8%
Q1 20249 May
EPS$-0.17
Miss 13.3%
Q4 202320 Mar
EPS$-0.13
Miss 8.3%
Q3 202314 Nov
EPS$-0.13
Miss 8.3%
Q2 202310 Aug
EPS$-0.16
Miss 60.0%
Q1 202311 May
EPS$-0.50
Miss 51.5%
Q4 202216 Mar
EPS$-0.45
Miss 221.6%
Q3 202210 Nov
EPS$-0.44
Miss 46.7%
Q2 202211 Aug
EPS$-0.43
Miss 59.3%
Q1 202212 May
EPS$-0.27
Miss 42.1%
Q4 202124 Mar
EPS$-0.27
Miss 145.4%
Q3 202116 Dec
EPS$-0.15
Q3 202118 Nov
EPS$-0.12
Q4 202031 Mar
EPS$-0.03
Q4 202022 Feb
EPS$-0.04
Miss 109.3%
Q3 202029 Oct
EPS$0.45
Beat 18.4%
Q2 202030 Jul
EPS$0.35
Beat 118.8%
Q1 20206 May
EPS$0.45
Beat 4.7%
Q4 201926 Feb
EPS$0.48
Beat 0.0%
Q3 20195 Nov
EPS$0.52
Beat 4.0%
Q2 201930 Jul
EPS$0.53
Beat 17.8%
Q1 201925 Apr
EPS$0.42
Beat 2.4%
Q4 201821 Feb
EPS$0.56
Beat 30.2%
Q3 201830 Oct
EPS$0.53
Beat 65.6%
Q2 201825 Jul
EPS$0.46
Beat 48.4%
Q1 201825 Apr
EPS$0.39
Beat 69.6%
Q4 201722 Feb
EPS$0.32
Beat 33.3%
Q3 20177 Nov
EPS$0.16
Miss 36.0%
Q2 20178 Aug
EPS$0.23
Beat 9.5%
Q1 20173 May
EPS$0.16
Beat 0.0%
Q4 201622 Feb
EPS$0.23
Beat 27.8%
Q3 20162 Nov
EPS$0.21
Beat 16.7%
Q2 20162 Aug
EPS$0.20
Beat 17.6%
Q1 201626 Apr
EPS$0.20
Beat 100.0%
Q4 201517 Feb
EPS$0.15
Beat 36.4%
Q3 20159 Nov
EPS$0.13
Beat 30.0%
Q2 20156 Aug
EPS$0.12
Beat 33.3%
Q1 20156 May
EPS$0.06
Beat 200.0%
Q4 201419 Feb
EPS$0.05
Miss 16.7%
Q3 201430 Oct
EPS$0.06
Beat 200.0%
Q2 20141 Aug
EPS$0.02
Beat 50.0%
Q1 20146 May
EPS$-0.04
Q4 201326 Feb
EPS$0.00
Beat 100.0%
Q3 20136 Nov
EPS$-0.12
Q3 20135 Nov
EPS$-0.12
Miss 500.0%
Q4 201231 Mar
EPS$-0.08
Q3 201231 Dec
EPS$-0.17
Q3 20125 Nov
EPS$-0.12
Miss 33.3%
Q2 20128 Aug
EPS$-0.05
Miss 75.0%
Q1 20128 May
EPS$-0.10
Beat 9.1%
Q4 201122 Feb
EPS$-0.04
Beat 75.0%
Q3 20118 Nov
EPS$-0.21
Miss 162.5%
Q2 20118 Aug
EPS$-0.05
Beat 16.7%
Q1 20113 May
EPS$-0.02
Beat 86.7%
Q4 201017 Feb
EPS$-0.13
Beat 18.8%
Q3 20108 Nov
EPS$-0.25
Miss 400.0%
Q2 201028 Jul
EPS$-0.02
Beat 80.0%
Q1 201028 Apr
EPS$-0.13
Beat 27.8%
Q4 200917 Feb
EPS$-0.24
Miss 71.4%
Q3 20096 Nov
EPS$-0.10
Miss 481.1%
Q2 20095 Aug
EPS$0.06
Beat 20.0%
Q1 200930 Apr
EPS$0.04
Beat 27.3%
Q4 200817 Feb
EPS$0.16
Beat 6.7%
Q3 200830 Oct
EPS$0.11
Beat 10.0%
Q2 200822 Jul
EPS$0.08
Beat 14.3%
Q1 200829 Apr
EPS$0.02
Beat 0.0%
Q4 200731 Mar
EPS$-0.01
Q2 200730 Sept
EPS$0.59
Q1 200730 Jun
EPS$-0.65
Q4 200631 Mar
EPS$-0.65
Q3 200631 Dec
EPS$-0.93
Q2 200630 Sept
EPS$-0.57
Q1 200630 Jun
EPS$-0.38
Q4 200531 Mar
EPS$-0.38

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about BEAT

Which members of Congress have traded BEAT?
1 member of Congress has disclosed 1 trade in HeartBeam, Inc. (BEAT) under the STOCK Act: Brad Schneider.
When was BEAT most recently disclosed by Congress?
The most recent BEAT disclosure was a sale by Brad Schneider on 13 September 2013.
What is the total disclosed congressional trading volume for BEAT?
Members of Congress have disclosed approximately $8K in BEAT sales (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in BEAT?
This BEAT page updates as soon as new STOCK Act disclosures are filed for HeartBeam, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.